本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Nautilus Biotechnolgy, Inc.

0.8816
-0.0454-4.90%
盤後0.90900.0274+3.11%19:17 EDT
成交量:19.16萬
成交額:16.68萬
市值:1.11億
市盈率:-1.61
高:0.9400
開:0.9400
低:0.8315
收:0.9270
資料載入中...
2021/11/02

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/08/26

超過5%披露

SC 13D - General statement of acquisition of beneficial ownership
2021/08/10

重要事件披露

8-K - Current report
2021/08/10

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/08/10

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2021/08/10

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2021/08/03

SEC問詢函

CORRESP [Cover] - Correspondence
2021/07/22

招股説明書

S-1 - General form for registration of securities under the Securities Act of 1933
2021/06/30

超過5%披露

SC 13D - General statement of acquisition of beneficial ownership
2021/06/21

超過5%披露

SC 13D - General statement of acquisition of beneficial ownership
2021/06/16

超過5%披露

SC 13D - General statement of acquisition of beneficial ownership
2021/06/16

超過5%披露

SC 13D - General statement of acquisition of beneficial ownership
2021/06/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/06/10

重要事件披露

8-K - Current report
2021/06/08

企業合併公告

425 - Prospectuses and communications, business combinations
2021/06/08

重要事件披露

8-K - Current report
2021/06/01

重要事件披露

8-K - Current report
2021/06/01

企業合併公告

425 - Prospectuses and communications, business combinations
2021/05/13

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/05/12

SEC問詢函

CORRESP [Cover] - Correspondence